Quick Answer
NIKA PHARMACEUTICALS, INC reported Stockholders Equity of -$297.6 thousand for fiscal year 2025.
NIKA PHARMACEUTICALS, INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$297.6K | -34.5% |
| 2024 | -$221.2K | -169.3% |
| 2023 | -$82.1K | -374.4% |
| 2022 | -$17.3K | +26.7% |
| 2021 | -$23.6K | -165.2% |
| 2020 | -$8.9K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$260.5K | -30.0% | -3.2% |
| June 30, 2025 | -$252.6K | -21.0% | -7.8% |
| March 31, 2025 | -$234.2K | -4.3% | -5.9% |
| December 31, 2024 | -$221.2K | -169.3% | -10.4% |
| September 30, 2024 | -$200.4K | -167.8% | +4.0% |
| June 30, 2024 | -$208.8K | -222.7% | +7.0% |
| March 31, 2024 | -$224.5K | -508.6% | -173.3% |
| December 31, 2023 | -$82.1K | -374.4% | -9.8% |
- NIKA PHARMACEUTICALS, INC showed a decrease of -34.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, NIKA PHARMACEUTICALS, INC’s stockholders equity has declined by 3241.5% (from -$8.9 thousand to -$297.6 thousand).
- The most recent figure is from NIKA PHARMACEUTICALS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: